ERBB2 and breast carcinoma: Recently, the immunohistochemical analyses of expression of estrogen receptor (ER), progesterone receptor (PR), and human epidermal growth factor receptor 2 (HER2), are widely used to divide into 4 breast cancer subtypes (BCSs).